Laurus Labs Limited (LAURUSLABS.NS)
INR 571.5
(0.8%)
INR 571.5
(0.8%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 50.01 Billion | 60.4 Billion | 48.88 Billion | 47.23 Billion | 27.58 Billion | 22.4 Billion |
| Cost of Revenue | 34.56 Billion | 27.74 Billion | 22.48 Billion | 21.97 Billion | 14.44 Billion | 12.61 Billion |
| Gross Profit | 15.44 Billion | 32.66 Billion | 26.4 Billion | 25.25 Billion | 13.14 Billion | 9.78 Billion |
| Operating Expenses | 11.9 Billion | 19.98 Billion | 14.67 Billion | 11.79 Billion | 9.35 Billion | 7.65 Billion |
| Selling, General and Administrative Expenses | 2.01 Billion | 1.79 Billion | 1.63 Billion | 1.4 Billion | 1.05 Billion | 584.8 Million |
| Research and Development Expenses | 2.41 Billion | 255.9 Million | 294.7 Million | 172.9 Million | 151.77 Million | 131.51 Million |
| Other Expenses | 263.4 Million | 60 Million | 8.7 Million | 41 Million | 46.42 Million | 57.94 Million |
| Cost and Expenses | 46.47 Billion | 47.72 Billion | 37.15 Billion | 33.76 Billion | 23.79 Billion | 20.27 Billion |
| Operating Income | 3.94 Billion | 12.94 Billion | 11.75 Billion | 13.5 Billion | 3.83 Billion | 2.14 Billion |
| Interest Expense | 1.79 Billion | 1.65 Billion | 757.6 Million | 561.2 Million | 733.88 Million | 742.3 Million |
| Income Tax Expense | 681.5 Million | 3.12 Billion | 2.51 Billion | 3.17 Billion | 383.38 Million | 259.88 Million |
| Earnings before Tax | 2.36 Billion | 11.08 Billion | 10.83 Billion | 13.01 Billion | 2.93 Billion | 1.19 Billion |
| Net Income | 1.6 Billion | 7.9 Billion | 8.27 Billion | 9.83 Billion | 2.55 Billion | 937.64 Million |
| Earnings Per Share Basic | 2.98 | 14.69 | 15.42 | 18.36 | 4.79 | 1.77 |
| Earnings Per Share Diluted | 2.97 | 14.64 | 15.35 | 18.28 | 4.79 | 1.76 |
| Weighted Average Shares Outstanding | 538.75 Million | 537.73 Million | 536.81 Million | 535.74 Million | 533.42 Million | 531.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 539.66 Million | 539.6 Million | 539.16 Million | 538.12 Million | 533.45 Million | 532.58 Million |
| Gross Margin | 0.31 | 0.54 | 0.54 | 0.53 | 0.48 | 0.44 |
| EBIT Margin | 0.16 | 0.26 | 0.29 | 0.33 | 0.20 | 0.16 |
| Profit Margin | 0.03 | 0.13 | 0.17 | 0.21 | 0.09 | 0.04 |
| EBITDA | 8 Billion | 15.75 Billion | 14.27 Billion | 15.72 Billion | 5.59 Billion | 3.6 Billion |
| Earnings Before Tax Margin | 0.08 | 0.21 | 0.24 | 0.29 | 0.14 | 0.10 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 12.23 Billion | 11.94 Billion | 14.39 Billion | 50.4 Billion | 11.94 Billion | 12.24 Billion |
| Cost of Revenue | 5.48 Billion | 8.16 Billion | 9.85 Billion | 34.56 Billion | 5.45 Billion | 5.81 Billion |
| Gross Profit | 6.75 Billion | 3.78 Billion | 4.54 Billion | 15.83 Billion | 6.49 Billion | 6.43 Billion |
| Operating Expenses | 6.04 Billion | 3.12 Billion | 3.15 Billion | 11.9 Billion | 5.66 Billion | 5.48 Billion |
| Selling, General and Administrative Expenses | 3.18 Billion | 2.48 Billion | 3.15 Billion | - | 2.46 Billion | 2.33 Billion |
| Research and Development Expenses | - | 640 Million | 690 Million | - | 670 Million | 580 Million |
| Other Expenses | 6.04 Billion | 25.1 Million | 185.3 Million | 263.4 Million | 24.3 Million | 17.8 Million |
| Cost and Expenses | 11.52 Billion | 11.29 Billion | 13 Billion | 46.47 Billion | 11.11 Billion | 11.29 Billion |
| Operating Income | 708.2 Million | 651.4 Million | 1.39 Billion | 3.92 Billion | 854.4 Million | 962.8 Million |
| Interest Expense | 526.1 Million | 491.9 Million | 505 Million | 1.82 Billion | 508.2 Million | 423.9 Million |
| Income Tax Expense | 50.9 Million | 62.5 Million | 319.5 Million | 681.5 Million | 94.5 Million | 145.7 Million |
| Earnings before Tax | 228.1 Million | 184.6 Million | 1.07 Billion | 2.36 Billion | 346.2 Million | 538.9 Million |
| Net Income | 198.4 Million | 125.1 Million | 756.1 Million | 1.6 Billion | 231.4 Million | 369.5 Million |
| Earnings Per Share Basic | 0.37 | 0.23 | 1.40 | - | 0.43 | 0.69 |
| Earnings Per Share Diluted | 0.37 | 0.23 | 1.40 | - | 0.43 | 0.68 |
| Weighted Average Shares Outstanding | 536.21 Million | 539.15 Million | 540.07 Million | 538.75 Million | 538.96 Million | 538.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 536.21 Million | 539.15 Million | 540.07 Million | 540.57 Million | 538.96 Million | 543.38 Million |
| Gross Margin | 0.55 | 0.32 | 0.32 | 0.31 | 0.54 | 0.53 |
| EBIT Margin | 0.15 | 0.14 | 0.17 | - | 0.15 | 0.15 |
| Profit Margin | 0.02 | 0.01 | 0.05 | 0.03 | 0.02 | 0.03 |
| EBITDA | 1.82 Billion | 1.71 Billion | 2.41 Billion | - | 1.83 Billion | 1.89 Billion |
| Earnings Before Tax Margin | 0.06 | 0.05 | 0.10 | 0.08 | 0.07 | 0.08 |
EVERFIN
SRICHA
BKS
1897
SANGHVIMOV
ALKYLAMINE